- Home
- KPLT vs ACXP Comparison
KPLT vs ACXP Comparison
Compare KPLT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- ACXP
- Stock Information
- Founded
- KPLT 2012
- ACXP 2017
- Country
- KPLT United States
- ACXP United States
- Employees
- KPLT N/A
- ACXP N/A
- Industry
- KPLT Diversified Commercial Services
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- KPLT Consumer Discretionary
- ACXP Health Care
- Exchange
- KPLT Nasdaq
- ACXP Nasdaq
- Market Cap
- KPLT 33.2M
- ACXP 31.4M
- IPO Year
- KPLT N/A
- ACXP 2021
- Fundamental
- Price
- KPLT $5.92
- ACXP $0.83
- Analyst Decision
- KPLT Hold
- ACXP Strong Buy
- Analyst Count
- KPLT 2
- ACXP 1
- Target Price
- KPLT $12.00
- ACXP $12.00
- AVG Volume (30 Days)
- KPLT 24.0K
- ACXP 248.6K
- Earning Date
- KPLT 11-06-2024
- ACXP 11-12-2024
- Dividend Yield
- KPLT N/A
- ACXP N/A
- EPS Growth
- KPLT N/A
- ACXP N/A
- EPS
- KPLT N/A
- ACXP N/A
- Revenue
- KPLT $241,789,000.00
- ACXP N/A
- Revenue This Year
- KPLT $12.92
- ACXP N/A
- Revenue Next Year
- KPLT $6.30
- ACXP N/A
- P/E Ratio
- KPLT N/A
- ACXP N/A
- Revenue Growth
- KPLT 14.99
- ACXP N/A
- 52 Week Low
- KPLT $5.79
- ACXP $0.72
- 52 Week High
- KPLT $23.54
- ACXP $5.28
- Technical
- Relative Strength Index (RSI)
- KPLT 36.71
- ACXP 33.67
- Support Level
- KPLT $6.09
- ACXP $0.72
- Resistance Level
- KPLT $6.91
- ACXP $0.91
- Average True Range (ATR)
- KPLT 0.48
- ACXP 0.11
- MACD
- KPLT -0.01
- ACXP 0.02
- Stochastic Oscillator
- KPLT 1.23
- ACXP 24.42
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.